-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBOTT LAUNCHES WHOLE-GENOME SEQUENCING ONCODETECT® MOLECULAR RESIDUAL DISEASE (MRD) TEST TO DETECT TRACES OF CANCER DURING AND AFTER TREATMENT

Reuters·10/26/2026 13:00:07

Please log in to view news